Jérôme Avouac Selected Research

Jérôme Avouac Research Topics

Disease

31	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 03/2011
21	Rheumatoid Arthritis 01/2024 - 02/2014
20	Fibrosis (Cirrhosis) 08/2023 - 03/2011
9	Inflammation (Inflammations) 12/2023 - 03/2011
8	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 01/2018
8	COVID-19 08/2023 - 01/2021
7	Rheumatic Diseases (Rheumatism) 08/2023 - 03/2014
6	Arthritis (Polyarthritis) 08/2023 - 07/2013
6	digital ulcers 01/2022 - 03/2010
6	Pulmonary Hypertension 01/2018 - 07/2015
4	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 03/2011
4	Infections 08/2023 - 01/2022
4	Connective Tissue Diseases (Connective Tissue Disease) 08/2023 - 05/2015
4	Vascular Remodeling 01/2022 - 11/2011
4	Neoplasms (Cancer) 11/2021 - 03/2008
4	Diffuse Scleroderma (Progressive Systemic Sclerosis) 07/2021 - 04/2010
4	Disease Progression 11/2020 - 01/2016
3	Pain (Aches) 12/2023 - 01/2007
3	Synovitis 01/2023 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 07/2009
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 05/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 01/2014
3	Hypoxia (Hypoxemia) 01/2016 - 08/2011
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 12/2014
2	Venous Thromboembolism 01/2023 - 12/2022
2	Necrosis 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 06/2021 - 12/2020
2	Heart Failure 11/2019 - 01/2014
2	Bronchiolitis Obliterans Syndrome 01/2018 - 12/2016
2	Immune System Diseases (Immune Disorders) 01/2016 - 05/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024
1	Cryoglobulinemia 12/2023
1	Vasculitis (Vasculitides) 08/2023
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2023
1	Monoclonal Gammopathy of Undetermined Significance 08/2023
1	Diabetes Mellitus 05/2023
1	Lupus Nephritis 02/2023
1	Axial Spondyloarthritis 01/2023
1	Ulcerative Colitis 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2008
9	Rituximab (Mabthera)FDA Link 12/2023 - 10/2014
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 03/2011
7	AntibodiesIBA 12/2023 - 12/2014
6	CollagenIBA 08/2023 - 05/2012
5	Janus Kinase InhibitorsIBA 12/2023 - 01/2021
5	Abatacept (Orencia)FDA Link 01/2021 - 07/2013
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 05/2012
3	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 01/2022
3	C-Reactive ProteinIBA 12/2023 - 12/2020
3	tocilizumab (atlizumab)FDA Link 08/2023 - 07/2013
3	Anti-Citrullinated Protein AntibodiesIBA 07/2023 - 12/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2014
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 02/2014
3	erucylphosphocholineIBA 04/2013 - 11/2011
2	baricitinibIBA 12/2023 - 07/2021
2	Rheumatoid FactorIBA 12/2023 - 01/2023
2	tixagevimabIBA 08/2023 - 12/2022
2	cilgavimabIBA 08/2023 - 12/2022
2	Chimeric Antigen ReceptorsIBA 08/2023 - 11/2021
2	Antirheumatic Agents (DMARD)IBA 08/2023 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 05/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2023 - 06/2021
2	Semaphorins (Semaphorin)IBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 12/2022 - 06/2013
2	nintedanibIBA 01/2022 - 10/2021
2	AutoantibodiesIBA 01/2022 - 10/2015
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2020 - 01/2019
2	Carbon MonoxideIBA 01/2019 - 01/2014
2	pro-brain natriuretic peptide (1-76)IBA 07/2015 - 02/2014
2	TroponinIBA 07/2015 - 02/2014
2	CD226 antigenIBA 01/2015 - 06/2013
2	indium-bleomycinIBA 11/2014 - 06/2014
2	CytokinesIBA 07/2014 - 03/2014
2	Hydroxyproline (4 Hydroxyproline)IBA 06/2013 - 03/2011
1	Lenalidomide (CC 5013)FDA Link 01/2024
1	Prostaglandins AIBA 12/2023
1	Arsenic Trioxide (Trisenox)FDA Link 12/2023
1	Janus KinasesIBA 12/2023
1	SS-A antibodiesIBA 12/2023
1	CarbonIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 08/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2023
1	sarilumabIBA 01/2023
1	amsonic acid (DAS)IBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Inosine Triphosphate (ITP)IBA 01/2023
1	cilgavimab and tixagevimab drug combinationIBA 12/2022
1	VaccinesIBA 12/2022
1	anti-scl-70 autoantibodiesIBA 11/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Hypochlorous Acid (Hypochlorite)IBA 01/2022

Therapy/Procedure

17	Therapeutics 12/2023 - 03/2008
3	Immunotherapy 06/2017 - 03/2014
2	Biological Therapy 01/2022 - 03/2014
1	Secondary Prevention 12/2022
1	Aftercare (After-Treatment) 12/2022
1	Injections 01/2022